Compare AMZE & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMZE | ACON |
|---|---|---|
| Founded | 2019 | 2008 |
| Country | United States | United States |
| Employees | 28 | 11 |
| Industry | Beverages (Production/Distribution) | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9M | 8.1M |
| IPO Year | N/A | N/A |
| Metric | AMZE | ACON |
|---|---|---|
| Price | $0.14 | $3.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.00 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 13.0M | 59.1K |
| Earning Date | 05-19-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1,986.62 | $87.22 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.11 | $2.34 |
| 52 Week High | $11.76 | $12.03 |
| Indicator | AMZE | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 43.49 | 57.91 |
| Support Level | $0.11 | $2.98 |
| Resistance Level | $0.20 | $3.52 |
| Average True Range (ATR) | 0.02 | 0.16 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 12.89 | 77.86 |
Amaze Holdings Inc is a technology-enabled, creator-powered commerce platform that enables creators, brands, and consumers to transact at scale. The Company provides infrastructure for creators and brands to design, launch, market, and fulfill products. The Company operates in two segments: E-commerce / Subscriptions, which includes the Amaze platform and creator commerce operations supporting product sales, subscription offerings, and digital content delivery; and Wine Products, which includes the sale of Fresh Vine wines through wholesale and direct-to-consumer channels across the United States and Puerto Rico.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.